As of Feb 17
| +0.01 / +1.43%|
The 2 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.00. The median estimate represents a +181.69% increase from the last price of 0.71.
The current consensus among 2 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.